Novelis Appoints New Independent Director to Board
June 30 2006 - 6:45AM
PR Newswire (US)
ATLANTA, June 30 /PRNewswire-FirstCall/ -- Novelis Inc. (NYSE:NVL)
(TSX: NVL) today announced that it has appointed a new independent
director, Edward A. Blechschmidt, to its Board of Directors. Mr.
Blechschmidt retired in 2002 as Chairman and Chief Executive
Officer of Gentiva Health Services, Inc., a leading provider of
specialty pharmaceutical and home health care services that was
spun off from Olsten Corporation and taken public. He remained a
director until May 2005. This appointment takes effect immediately
and continues until Novelis' 2006 annual meeting, when Mr.
Blechschmidt will be nominated for election to serve in the coming
year. The annual meeting has been delayed and will take place by
the end of 2006. William T. Monahan, Chairman of the Board, said,
"We are very pleased to welcome Ed Blechschmidt to Novelis' Board
of Directors. Ed's strong financial background, operating
experience and spin-related expertise, combined with his focus on
generating shareholder value, will make him a valuable addition to
our Board as Novelis becomes a world-class organization." Mr.
Blechschmidt fills the second of two vacancies that resulted from
the previously announced increase in the maximum size of Novelis'
Board from 12 to 14 members. The first vacancy was filled by Kevin
M. Twomey, who was appointed to the Board in May. Before joining
Gentiva in 2000, Mr. Blechschmidt, 53, served as Chief Executive
Officer and a director of Olsten Corporation, the conglomerate from
which Gentiva Health Services was spun off. He served as President
of Olsten from October 1998 to March 1999. He also served as
President and Chief Executive Officer of Siemens Nixdorf Americas
and Siemens Pyramid Technologies from July 1996 to October 1998.
Prior to that, he spent more than 20 years with Unisys Corporation,
where he held positions of increasing responsibility in finance,
administration and operations, including Chief Financial Officer.
Mr. Blechschmidt serves as a director of HealthSouth Corp., having
joined the Board in 2004, Lionbridge Technologies, Inc., Option
Care, Inc., and Columbia Laboratories, Inc. He serves as Chair of
the Audit Committees of the Boards of HealthSouth and Lionbridge
Technologies. Mr. Blechschmidt earned his bachelor's degree in
business from Arizona State University. Novelis is the global
leader in aluminum rolled products and aluminum can recycling. The
company operates in 11 countries and has approximately 13,000
employees. Novelis has the unrivaled capability to provide its
customers with a regional supply of technologically sophisticated
rolled aluminum products throughout Asia, Europe, North America and
South America. Through its advanced production capabilities, the
company supplies aluminum sheet and foil to the automotive and
transportation, beverage and food packaging, construction and
industrial, and printing markets. For more information, visit
http://www.novelis.com/. Statements made in this news release which
describe Novelis' intentions, expectations or predictions may be
forward-looking statements within the meaning of securities laws.
Examples of forward-looking statements in this news release
include, among other matters, Novelis' ability to execute on its
business strategy, hold an annual meeting by the end of 2006, and
that Mr. Blechschmidt will be nominated for election at such
meeting. Novelis cautions that, by their nature, forward-looking
statements involve risk and uncertainty, that the annual meeting
could be further delayed in the event Novelis has not issued its
annual report on Form 10-K for the fiscal year ended 2005 by the
end of 2006, and that Mr. Blechschmidt has not yet been nominated
for election at the 2006 annual meeting. We do not intend, and we
disclaim any obligation, to update any forward-looking statements,
whether as a result of new information, future events or otherwise.
Please refer to important risk factors listed under the caption
"Special Note Regarding Forward-Looking Statements and Market Data"
in our quarterly report on Form 10-Q for the period ended September
30, 2005, as filed with the SEC. The risk factors included in our
quarterly report on Form 10-Q for the period ended September 30,
2005, are specifically incorporated by reference into this news
release. DATASOURCE: Novelis Inc. CONTACT: Media: Charles Belbin,
+1-404-814-4260, , or Investors: Holly K. Ash, +1-404-814-4212, ,
both of Novelis Web site: http://www.novelis.com/
Copyright
Novelis Inc (NYSE:NVL)
Historical Stock Chart
From Jan 2025 to Feb 2025
Novelis Inc (NYSE:NVL)
Historical Stock Chart
From Feb 2024 to Feb 2025